H.R.7336

ALS Better Care Act

Introduced·2/3/26

Overview

The ALS Better Care Act establishes comprehensive Medicare coverage for specialized services provided to individuals diagnosed with amyotrophic lateral sclerosis. The legislation creates a new category of covered services specifically tailored to the multidisciplinary care needs of ALS patients, addressing the progressive neurodegenerative nature of the disease through coordinated medical support. The bill recognizes that ALS patients require an integrated approach involving multiple healthcare disciplines and seeks to eliminate financial barriers to accessing this care by providing coverage without cost-sharing requirements. By amending the Social Security Act to include ALS-related services as a distinct benefit category, the legislation aims to improve quality of life and care coordination for individuals living with this terminal illness while establishing a sustainable payment framework for qualified providers who deliver these specialized services.

Core Provisions

The bill amends the Social Security Act by adding new sections that define and establish payment mechanisms for ALS-related services. Section 1861(nnn)(1) creates a comprehensive definition of ALS-related services encompassing eight distinct categories of care: specialized physician or nurse practitioner support, occupational therapy, speech pathology, physical therapy, dietary support, respiratory support, registered nurse support, and coordination of durable medical equipment. The legislation defines a covered ALS individual under Section 1861(nnn)(2) as any person who has been medically determined to have amyotrophic lateral sclerosis, without additional qualifying criteria. Section 1834(aa) establishes the payment framework, mandating that the Secretary of Health and Human Services implement a single payment system for these services with annual adjustments based on the ALS services market basket percentage increase. The payment structure requires assignment-related billing and explicitly prohibits any cost-sharing by beneficiaries under Section 1834(aa)(5). Section 1834(aa)(6) defines qualified providers as those capable of furnishing ALS-related services and meeting Secretary-prescribed requirements, though specific qualification standards are delegated to regulatory development.

Key Points

  • Creates new Medicare benefit category for ALS-related services under Social Security Act §1861(nnn)
  • Establishes eight categories of covered ALS services including physician support, therapy services, dietary support, respiratory support, nursing care, and equipment coordination
  • Implements single payment system with annual market basket adjustments under §1834(aa)(3)
  • Eliminates all cost-sharing requirements for covered ALS individuals
  • Requires assignment-related basis for all payments to qualified providers
  • Delegates provider qualification standards to Secretary of Health and Human Services

Legal References

  • Social Security Act, 42 U.S.C. § 1395x
  • Social Security Act § 1861(nnn)(1) - Definition of ALS-related services
  • Social Security Act § 1861(nnn)(2) - Definition of covered ALS individual
  • Social Security Act § 1834(aa) - Payment for ALS-related services
  • Social Security Act § 1834(aa)(3) - Single payment system
  • Social Security Act § 1834(aa)(5) - Assignment and cost-sharing provisions
  • Social Security Act § 1834(aa)(6) - Qualified provider definition

Implementation

The Secretary of Health and Human Services bears primary responsibility for implementing the ALS-related services benefit, with authority under Section 1834(aa)(7) to proceed through either program instruction or formal rulemaking procedures. This dual-track authority provides flexibility to expedite implementation while maintaining regulatory oversight. The Comptroller General of the United States assumes a critical oversight role under Section 1834(aa)(4), with mandatory reporting requirements beginning January 1, 2027, and continuing every third year thereafter. These reports must recommend appropriate single payment amounts for ALS-related services, providing an independent assessment mechanism to ensure payment adequacy. The Director of the National Institute of Neurological Disorders and Stroke and the American Medical Association are identified as key stakeholders, suggesting their involvement in developing clinical standards and payment methodologies. The payment system incorporates automatic annual adjustments tied to the ALS services market basket percentage increase, creating a self-adjusting mechanism that responds to cost trends without requiring repeated legislative action. The Secretary must establish qualification requirements for providers, though the legislation does not specify whether these will be implemented through certification, accreditation, or other credentialing mechanisms.

Key Points

  • Secretary of Health and Human Services authorized to implement through program instruction or rulemaking under §1834(aa)(7)
  • Comptroller General must submit payment recommendation reports by January 1, 2027, and every third year thereafter
  • Automatic annual payment adjustments based on ALS services market basket percentage increase
  • Secretary must prescribe qualification requirements for providers furnishing ALS-related services
  • National Institute of Neurological Disorders and Stroke Director identified as key stakeholder
  • American Medical Association designated as participating entity in implementation

Legal References

  • Social Security Act § 1834(aa)(4) - Comptroller General reporting requirements
  • Social Security Act § 1834(aa)(7) - Implementation authority

Impact

The legislation directly benefits all Medicare beneficiaries diagnosed with amyotrophic lateral sclerosis by providing comprehensive coverage for multidisciplinary care services without imposing any out-of-pocket costs. This represents a significant expansion of Medicare benefits for a population facing catastrophic healthcare expenses due to a progressive, terminal illness. The elimination of cost-sharing removes financial barriers that might otherwise prevent ALS patients from accessing necessary supportive services, potentially improving both quality of life and clinical outcomes. Qualified providers gain access to a new revenue stream with predictable payment rates adjusted annually for cost increases, though they must meet yet-to-be-defined qualification standards and accept assignment as a condition of participation. The Medicare program will experience increased expenditures, though the legislation does not include specific appropriations or cost estimates. The reference periods of 2022 through 2024 and 2026 through 2028 suggest data collection and analysis phases, with a 2030 evaluation point likely intended for assessing program effectiveness. The administrative burden on the Centers for Medicare & Medicaid Services will be substantial, requiring development of payment methodologies, provider qualification standards, claims processing systems, and oversight mechanisms. Healthcare providers will face compliance costs associated with meeting qualification requirements and adapting billing systems to accommodate the new benefit category.

Key Points

  • All Medicare beneficiaries with ALS diagnosis receive coverage for eight categories of specialized services
  • Complete elimination of cost-sharing reduces financial burden on ALS patients and families
  • Qualified providers receive predictable payments with annual inflation adjustments
  • Medicare program expenditures increase without specified appropriation limits
  • Implementation timeline suggests data collection periods 2022-2024 and 2026-2028 with 2030 evaluation
  • Administrative costs for CMS include payment system development, provider credentialing, and claims processing

Legal Framework

The legislation operates under Congress's constitutional authority to regulate the Medicare program through the spending power and the Commerce Clause. The amendments to the Social Security Act represent a direct exercise of federal authority over a wholly federal program, avoiding federalism concerns that might arise with state-federal cooperative programs. The statutory framework builds upon existing Medicare payment structures while creating a distinct benefit category specifically for ALS-related services. The delegation of rulemaking authority to the Secretary of Health and Human Services follows established administrative law principles, providing sufficient statutory guidance through the definition of covered services and the mandate for a single payment system. The requirement for assignment-related billing and prohibition on cost-sharing represent binding statutory mandates that override any contrary regulatory provisions or private contractual arrangements. The Comptroller General's reporting requirement creates an independent oversight mechanism outside the executive branch, providing Congress with expert analysis to inform future legislative adjustments. The legislation does not include explicit judicial review provisions, meaning challenges to implementation would proceed under the Administrative Procedure Act's general framework for reviewing agency action. The federal nature of Medicare means no preemption analysis is necessary, as state law does not govern federal benefit programs, though state licensing requirements for healthcare providers remain applicable to qualified provider determinations.

Legal References

  • U.S. Constitution, Article I, Section 8 - Spending Clause
  • U.S. Constitution, Article I, Section 8, Clause 3 - Commerce Clause
  • Social Security Act, 42 U.S.C. § 1395 et seq. - Medicare program statutory authority
  • Administrative Procedure Act, 5 U.S.C. § 551 et seq. - Rulemaking and judicial review framework

Critical Issues

The legislation faces several implementation challenges that could affect its effectiveness and sustainability. The absence of specific appropriations or cost estimates creates fiscal uncertainty, potentially exposing the Medicare program to unanticipated expenditures without corresponding revenue sources or offsets. The delegation of provider qualification standards to the Secretary without statutory criteria risks inconsistent implementation and may create barriers to access if requirements are overly restrictive or inadequately defined. The single payment system approach, while administratively efficient, may not adequately account for geographic variation in costs or differences in patient acuity, potentially creating access disparities or payment inadequacies in high-cost areas. The market basket adjustment mechanism assumes that historical cost trends will continue, which may not hold true if treatment patterns change or new therapies emerge. The three-year cycle for Comptroller General reports may be insufficient to respond to rapid changes in the ALS treatment landscape or payment adequacy concerns. The requirement for assignment-related billing eliminates provider flexibility and may discourage participation if payment rates are perceived as inadequate, particularly given the intensive nature of ALS care coordination. The lack of sunset provisions means the program continues indefinitely without mandatory reassessment, though the reporting requirements provide opportunities for congressional oversight. Constitutional challenges appear unlikely given the clear federal authority over Medicare, but administrative law challenges to specific implementation decisions remain possible. The legislation does not address potential conflicts with existing Medicare benefits or coordination with other federal programs serving ALS patients, creating potential gaps or duplications in coverage.

Key Points

  • No specific appropriations or cost estimates create fiscal uncertainty for Medicare program
  • Undefined provider qualification standards risk access barriers or inconsistent implementation
  • Single payment system may not account for geographic cost variation or patient acuity differences
  • Market basket adjustments assume stable cost trends that may not reflect treatment innovations
  • Three-year reporting cycle may be insufficient for responsive payment adjustments
  • Mandatory assignment requirement may discourage provider participation if rates are inadequate
  • Absence of sunset provisions eliminates automatic program reassessment mechanisms
  • No provisions address coordination with existing Medicare benefits or other federal ALS programs

Where it stands

Current
Energy And Commerce Committee
Next
Committee decision

Sponsors

Democratic CaucusRepublican Caucus

History

Feb 3

House

Introduced in House

Feb 3

House

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.